BELLUS HEALTH (BLU) Stocks
ABOUT BELLUS HEALTH
Bellus Health Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. The company’s product candidate, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus.
This product is a highly selective P2X3 inhibitor that has the potential to be a differentiated treatment option for patients that suffer from either condition.
The company is exploring how P2X3 activation contributes to irritation and pain, and whether inhibition of P2X3 receptors can help treat other afferent hypersensitization-related disorders.
OVERVIEW OF BELLUS HEALTH
In November 2018, Bellus Health Inc announced positive top-line results from the clinical Phase 1 study for BLU-5937, in which the product was shown to be safe and well tolerated.
The benign side effect profile, in combination with the anti-tussive effect demonstrated in several preclinical studies, further reinforces the company’s position that BLU-5937 has the potential to be a best-in-class therapeutic for chronic cough patients.
Based on the positive data from the Phase 1 study, the company expects to initiate a clinical Phase 2 study for BLU-5937 in chronic cough patients in mid-2019, with top-line results anticipated in mid-2020.
In December 2018, the company completed a US Dollar 35 million equity financing, with most of the offering subscribed by U.S. institutional healthcare investors.
Chronic cough can cause adverse physical, social, and psychosocial effects on health and quality of life. It is estimated that approximately 26 million adults in the United States suffer from chronic cough, with more than 2.6 million having refractory chronic cough lasting for more than a year.
There is no specific therapy approved for refractory chronic cough and treatment options are limited. The most advanced therapy in development has substantial tolerability issues, including significant taste alteration or loss.
BLU-5937 has the potential to be a differentiated treatment option for chronic cough, with little to no effect on taste. As such, the company’s development portfolio places it in a strong position to meet the growing need for treatment of this condition.
VISION & VALUES OF BELLUS HEALTH
Bellus Health Inc upholds values of ethical governance and transparent communications with all its stakeholders.
The company ensures that all its investments are conducted in accordance with strict regulatory requirements and provides all necessary reports and documentation in a prompt manner for full disclosure in line with the requirements of its stakeholders.
MARKET PERFORMANCE OF BELLUS HEALTH
Bellus Health Inc trades on the Toronto Stock Exchange (TSX), where investors can buy shares under the stock symbol -BLU.
Data from the company’s 2019 financial analysis shows that the company raised total gross proceeds of US Dollar 104.6 million through the issuing of common shares in the United States and Canada.
In September the company closed an equity offering for gross proceeds of US Dollar 92.2 million. The company intends to use these gross proceeds in order to fund research and development activities of its product pipeline.
The company is in a strong position to continue the development of its key product, for which the market has displayed a history of strong demand.
The delivery of this differentiated product puts the company in good stead to secure a rising share price for investors with strong long-term growth in dividends, providing a solid buy-in for those who choose to purchase shares today.
Buy BELLUS HEALTH stocks / shares – A Step by Step Guide how to Buy / Purchase BELLUS HEALTH Stocks or Shares online.
Before buying any stock or share one has to consider a few factors.
STEP 1: PROPER RESEARCH IS ESSENTIAL
Upon deciding you want to buy BELLUS HEALTH Stocks / Shares, it is critical for the serious investor to do proper research into the said company. Its values should align with those of the investor’s current portfolio. An investor needs to familiarise himself with the basics and history of the company, as well as its leadership and performance in the market. Its company reports should also be scrutinized.
Consultation with a brokerage firm can also assist in determining whether investing in a specific company will complement the investor’s current portfolio. The investment “risk ladder”, which identifies asset classes based on their relative riskiness, is another useful tool when determining which company’s stock / share is the best to buy.
STEP 2: CALCULATE THE AMOUNT OF INVESTMENT IN BELLUS HEALTH STOCKS / SHARES
It is important for an investor to monitor his total investment in stock in order to keep his portfolio aligned to his investment strategy. The overall value of his holdings will change with the fluctuation in stock prices, which can throw his portfolio off balance. To determine the amount to invest, multiply the number of shares of each stock by its current market price to determine the total investment in that specific stock. For example, if you own 100 shares of a US Dollar 5 stock, multiply 100 by US Dollar 5 to get US Dollar 500.
STEP 3: DECIDE ON THE STOCK / SHARE ORDER TYPE
Investors can choose from a market order, a limit order, a stop order (also referred to as a stop-loss order) or a buy/sell stop order. It is important to familiarise yourself with each type’s pros and cons before deciding which one will suit your current stock profile best. An investor should be guided in this choice by his investment objective.
STEP 4: OPEN A BROKERAGE ACCOUNT
A brokerage account – also known as taxable investment account – is similar to a retirement account, but more flexible. Where a retirement account has limitations on the amount of money that can be contributed annually, and restrictions on when funds can be withdrawn, a brokerage account is more flexible. The latter has no income or contribution limit and the investor can withdraw his money at any given time. This flexibility, together with its potential investment gains, makes a brokerage account more attractive to serious investors. Brokerage accounts are ideal for goals or savings that are further than five years away, but closer than retirement. It can also supplement an investor’s emergency savings.
STEP 5: COMMIT AND PURCHASE BELLUS HEALTH STOCKS / SHARES
Lastly, commit to the stock. Pro Tip: Monitor the value of your stock to ensure you have a growing stock value and dividend pay-out. Regularly check the share price online to ensure your investment delivers a positive return on investment. You are now a proud owner of BELLUS HEALTH stocks / shares.
5 Questions to ask yourself before purchasing any stocks or shares.
- Is it the best time to buy this stock / share?
- Should I buy BELLUS HEALTH stocks / shares in the current economic climate?
- Can I afford to buy this stock / share?
- What is the forecast of the stock / share growth?
- What is the current price per earning ration on the stock / share?